Hilary (Billy) Sheppard

Dr. Hilary (Billy) Sheppard

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2023 in Human Genetics
Verified
Journal Article
Open access
PDF file
JHJohn Murray Topp Hunt
John Murray Topp Hunt
CSChristopher Allan Samson
Christopher Allan Samson
ARAlex du Rand
Alex du Rand
HSHilary (Billy) Sheppard
Hilary (Billy) Sheppard
Genome editing using the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas) gene-editing system (CRISPR-Cas) is a valuable tool for fundamental and applied research applications. Significant improvements in editing efficacy have advanced genome editing strategies into phase 3 human clinical trials. However, recent studies suggest that our understanding of editing outcomes has lagged behind the developments made in generating the edits themselves. While many researchers have analyzed on- and off-target events through the lens of small insertions or deletions at predicted sites, screens for larger structural variants (SVs) and chromosomal abnormalities are not routinely performed. Full and comprehensive validation of on- and off-target effects is required to ensure reproducibility and to accurately assess the safety of future editing applications. Here we review SVs associated with CRISPR-editing in cells of human origin and highlight the methods used to detect and avoid them.

1 March 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DHDavid M. Heery
David M. Heery
SHSusan Hoare
Susan Hoare
SHSagair Hussain
Sagair Hussain
MPMalcolm G. Parker
Malcolm G. Parker
HSHilary (Billy) Sheppard
Hilary (Billy) Sheppard
An α-helical motif containing the sequence LXXLL is required for the ligand-dependent binding of transcriptional co-activators to nuclear receptors. By using a peptide inhibition assay, we have defined the minimal “core” LXXLL motif as an 8-amino acid sequence spanning positions −2 to +6 relative to the primary conserved leucine residue. In yeast two-hybrid assays, core LXXLL motif sequences derived from steroid receptor co-activator (SRC1), the 140-kDa receptor interacting protein (RIP140), and CREB-binding protein (CBP) displayed differences in selectivity and affinity for nuclear receptor ligand binding domains. Although core LXXLL motifs from SRC1 and RIP140 mediated strong interactions with steroid and retinoid receptors, three LXXLL motifs present in the global co-activator CBP were found to have very weak affinity for these proteins. Core motifs with high affinity for steroid and retinoid receptors were generally found to contain a hydrophobic residue at position −1 relative to the first conserved leucine and a nonhydrophobic residue at position +2. Our results indicate that variant residues in LXXLL core motifs influence the affinity and selectivity of co-activators for nuclear receptors.

1 March 2004 in Molecular Cell
Verified
Journal Article
Closed access
HLHeng-Hong Li
Heng-Hong Li
ALAndrew G Li
Andrew G Li
HSHilary (Billy) Sheppard
Hilary (Billy) Sheppard
XLXuan Liu
Xuan Liu

1 January 2001 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
HSHilary (Billy) Sheppard
Hilary (Billy) Sheppard
JHJanet C. Harries
Janet C. Harries
SHSagair Hussain
Sagair Hussain
CBCharlotte Bevan
Charlotte Bevan
DHDavid M. Heery
David M. Heery
The transcriptional activity of nuclear receptors is mediated by coactivator proteins, including steroid receptor coactivator 1 (SRC1) and its homologues and the general coactivators CREB binding protein (CBP) and p300. SRC1 contains an activation domain (AD1) which functions via recruitment of CBP and and p300. In this study, we have used yeast two-hybrid and in vitro interaction-peptide inhibition experiments to map the AD1 domain of SRC1 to a 35-residue sequence potentially containing two α-helices. We also define a 72-amino-acid sequence in CBP necessary for SRC1 binding, designated the SRC1 interaction domain (SID). We show that in contrast to SRC1, direct binding of CBP to the estrogen receptor is weak, suggesting that SRC1 functions primarily as an adaptor to recruit CBP and p300. In support of this, we show that the ability of SRC1 to enhance ligand-dependent nuclear receptor activity in transiently transfected cells is dependent upon the integrity of the AD1 region. In contrast, the putative histone acetyltransferase domain, the Per-Arnt-Sim basic helix-loop-helix domain, the glutamine-rich domain, and AD2 can each be removed without loss of ligand-induced activity. Remarkably, a construct corresponding to residues 631 to 970, which contains only the LXXLL motifs and the AD1 region of SRC1, retained strong coactivator activity in our assays.

18 February 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
YMYale S. Michaels
Yale S. Michaels
MBMike B. Barnkob
Mike B. Barnkob
HBHector Barbosa
Hector Barbosa
TBToni A. Baeumler
Toni A. Baeumler
MTMary K. Thompson
Mary K. Thompson
TFTudor A. Fulga
Tudor A. Fulga
Precise, analogue regulation of gene expression is critical for cellular function in mammals. In contrast, widely employed experimental and therapeutic approaches such as knock-in/out strategies are more suitable for binary control of gene activity. Here we report on a method for precise control of gene expression levels in mammalian cells using engineered microRNA response elements (MREs). First, we measure the efficacy of thousands of synthetic MRE variants under the control of an endogenous microRNA by high-throughput sequencing. Guided by this data, we establish a library of microRNA silencing-mediated fine-tuners (miSFITs) of varying strength that can be employed to precisely control the expression of user-specified genes. We apply this technology to tune the T-cell co-inhibitory receptor PD-1 and to explore how antigen expression influences T-cell activation and tumour growth. Finally, we employ CRISPR/Cas9 mediated homology directed repair to introduce miSFITs into the BRCA1 3′UTR, demonstrating that this versatile tool can be used to tune endogenous genes.

25 April 2003 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MTMoana Tercel
Moana Tercel
SSStephen M. Stribbling
Stephen M. Stribbling
HSHilary (Billy) Sheppard
Hilary (Billy) Sheppard
BSBronwyn G. Siim
Bronwyn G. Siim
KWKent Wu
Kent Wu
WDWilliam A. Denny
William A. Denny